» Articles » PMID: 36309742

Diabetes Mellitus Duration and Mortality in Patients Hospitalized with Acute Myocardial Infarction

Abstract

Background: Diabetes mellitus (DM) is associated with an increased mortality risk in patients hospitalized with acute myocardial infarction (AMI); however, no studies have investigated the impact of the duration of DM on in-hospital mortality. In this study, we evaluated in-hospital mortality in AMI patients according to DM status and its duration.

Methods: Using health administrative databases of Lombardy, DM patients≥50 years hospitalized with AMI from 2010 to 2019 were included in the analysis and were stratified according to the duration of DM: <5, 5-10, and > 10 years. The primary endpoint was mortality during AMI hospitalization and the secondary endpoint was 1-year mortality in comparison with No-DM patients. Logistic and Cox regressions analyses were used to estimate odds ratios (ORs, CI 95%) and hazard ratios (HRs, CI 95%) for the outcomes, according to DM status and duration and AMI type (STEMI and NSTEMI).

Results: Our study cohort comprised 29,566 and 109,247 DM and No-DM patients, respectively. Adjusted ORs and HRs showed a significantly higher risk of in-hospital mortality (OR 1.50, 95% CI 1.43-1.58) and 1-year mortality (HR 1.51, 95% CI 1.46-1.55) in DM patients in comparison with those without. These risks increased progressively with the duration of DM, with the highest risk observed in patients with DM duration ≥ 10 years (OR 1.59, 95% CI 1.50-1.69 for in-hospital mortality and HR 1.59, 95% CI 1.53-1.64 for 1-year mortality). These findings were similar in STEMI and in NSTEMI patients.

Conclusions: Our study demonstrates that the duration of DM parallels mortality risk in patients hospitalized with AMI, highlighting that DM duration should be considered as an important early prognostic risk factor in patients with AMI.

Citing Articles

Independent influence of type 2 diabetes on reduced cardiopulmonary fitness in patients after percutaneous coronary intervention: a cross-sectional study.

Liu Y, Li N, Zhang S, Feng Y, Zhang Y, Shao Y Sci Rep. 2025; 15(1):6071.

PMID: 39972067 PMC: 11839949. DOI: 10.1038/s41598-025-90281-z.


Machine learning approaches for risk prediction after percutaneous coronary intervention: a systematic review and meta-analysis.

Zaka A, Mutahar D, Gorcilov J, Gupta A, Kovoor J, Stretton B Eur Heart J Digit Health. 2025; 6(1):23-44.

PMID: 39846069 PMC: 11750198. DOI: 10.1093/ehjdh/ztae074.


Plasma tissue plasminogen activator-inhibitor complex levels in acute myocardial infarction patients: an observational study.

Feng Y, Su M, Xu H, Zhang S, Ma Y, Chen H BMC Cardiovasc Disord. 2024; 24(1):722.

PMID: 39707177 PMC: 11660627. DOI: 10.1186/s12872-024-04406-9.


Short- and long-term mortality in patients with type 2 diabetes after myocardial infarction- a nationwide registry study.

Kerola A, Juonala M, Kyto V Cardiovasc Diabetol. 2024; 23(1):390.

PMID: 39478565 PMC: 11526664. DOI: 10.1186/s12933-024-02479-6.


In-Hospital Mortality in Patients With Acute Myocardial Infarction: A Literature Overview.

Alnemer K Cureus. 2024; 16(8):e66729.

PMID: 39268294 PMC: 11390361. DOI: 10.7759/cureus.66729.


References
1.
Marenzi G, Cosentino N, Genovese S, Campodonico J, De Metrio M, Rondinelli M . Reduced Cardio-Renal Function Accounts for Most of the In-Hospital Morbidity and Mortality Risk Among Patients With Type 2 Diabetes Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction. Diabetes Care. 2019; 42(7):1305-1311. DOI: 10.2337/dc19-0047. View

2.
Rawshani A, Rawshani A, Franzen S, Eliasson B, Svensson A, Miftaraj M . Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes. N Engl J Med. 2017; 376(15):1407-1418. DOI: 10.1056/NEJMoa1608664. View

3.
Cosentino F, Grant P, Aboyans V, Bailey C, Ceriello A, Delgado V . 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2019; 41(2):255-323. DOI: 10.1093/eurheartj/ehz486. View

4.
Brown H, Waugh N, Jennings P . Microangiopathy as a prognostic indicator in diabetic patients suffering from acute myocardial infarction. Scott Med J. 1992; 37(2):44-6. DOI: 10.1177/003693309203700206. View

5.
DAscenzo F, Biondi-Zoccai G, Moretti C, Bollati M, Omede P, Sciuto F . TIMI, GRACE and alternative risk scores in Acute Coronary Syndromes: a meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients. Contemp Clin Trials. 2012; 33(3):507-14. DOI: 10.1016/j.cct.2012.01.001. View